Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LADIE: Fulvestrant + EGFR-TKI in Women with NSCLC
NCT01556191Phase 2Completed
- Sponsor
- IFCT
- Start
- May 2012
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fulvestrant in Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC), sponsored by IFCT. Started May 2012; status: completed.
02
Drugs
fulvestrant
03
Conditions
Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
Beyond the preview
Go deeper on NCT01556191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01556191.